The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Network pharmacology: curing causal mechanisms instead of treating symptoms
Open accessAbstract
For complex diseases, most drugs are highly ineffective, and the success rate of drug discovery is in constant decline. While low quality, reproducibility issues, and translational irrelevance of most basic and preclinical research have contributed to this, the current organ-centricity of medicine and the 'one disease-one target-one drug' dogma obstruct innovation in the most profound manner. Systems and network medicine and their therapeutic arm, network pharmacology, revolutionize how we define, diagnose, treat, and, ideally, cure diseases. Descriptive disease phenotypes are replaced by endotypes defined by causal, multitarget signaling modules that also explain respective comorbidities. Precise and effective therapeutic intervention is achieved by synergistic multicompound network pharmacology and drug repurposing, obviating the need for drug discovery and speeding up clinical translation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
KEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Mutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419
DrugBank: a comprehensive resource for in silico drug discovery and exploration
Wishart, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj067 · Cited by 3,892
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564
Goh, K.-I., Cusick, M. E., Valle, D., Childs, B., Vidal, M., & Barabási, A.-L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701361104 · Cited by 3,242
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Sanchez-Vega, F., Mina, M., Armenia, J., Chatila, W. K., Luna, A., La, K. C., Dimitriadoy, S., Liu, D. L., Kantheti, H. S., Saghafinia, S., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.035 · Cited by 3,201
Self-citationGenomic responses in mouse models poorly mimic human inflammatory diseases
Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., Richards, D. R., McDonald-Smith, G. P., Gao, H., Hennessy, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222878110 · Cited by 3,005
Diagnosing the decline in pharmaceutical R&D efficiency
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981
Believe it or not: how much can we rely on published data on potential drug targets?
Prinz, F., Schlange, T., & Asadullah, K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3439-c1 · Cited by 1,888
The Microenvironmental Landscape of Brain Tumors
Quail, D. F., & Joyce, J. A. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.02.009 · Cited by 1,862
PISCES: a protein sequence culling server
Wang, G., & Dunbrack, R. L. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg224 · Cited by 1,662
Uncovering disease-disease relationships through the incomplete interactome
Menche, J., Sharma, A., Kitsak, M., Ghiassian, S. D., Vidal, M., Loscalzo, J., & Barabási, A.-L. (2015) · Science · doi:10.1126/science.1257601 · Cited by 1,546
1,026 Experimental treatments in acute stroke
O'Collins, V. E., Macleod, M. R., Donnan, G. A., Horky, L. L., van der Worp, B. H., & Howells, D. W. (2006) · Annals of Neurology · doi:10.1002/ana.20741 · Cited by 1,460
Polypharmacy in elderly patients
Hajjar, E. R., Cafiero, A. C., & Hanlon, J. T. (2007) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2007.12.002 · Cited by 1,265
Personalized medicine: Time for one-person trials
Schork, N. J. (2015) · Nature · doi:10.1038/520609a · Cited by 1,223
Wen, P. Y., Weller, M., Lee, E. Q., Alexander, B. M., Barnholtz-Sloan, J. S., Barthel, F. P., Batchelor, T. T., Bindra, R. S., Chang, S. M., Chiocca, E. A., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa106 · Cited by 1,168
Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC
Turke, A. B., Zejnullahu, K., Wu, Y.-L., Song, Y., Dias-Santagata, D., Lifshits, E., Toschi, L., Rogers, A., Mok, T., Sequist, L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.11.022 · Cited by 1,059
Clinical Relevance of Biomarkers of Oxidative Stress
Frijhoff, J., Winyard, P. G., Zarkovic, N., Davies, S. S., Stocker, R., Cheng, D., Knight, A. R., Taylor, E. L., Oettrich, J., Ruskovska, T., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6317 · Cited by 909
Self-citationWikiPathways: a multifaceted pathway database bridging metabolomics to other omics research
Slenter, D. N., Kutmon, M., Hanspers, K., Riutta, A., Windsor, J., Nunes, N., Mélius, J., Cirillo, E., Coort, S. L., Digles, D., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1064 · Cited by 908
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
Takimoto, E., Champion, H. C., Li, M., Belardi, D., Ren, S., Rodriguez, E. R., Bedja, D., Gabrielson, K. L., Wang, Y., & Kass, D. A. (2005) · Nature Medicine · doi:10.1038/nm1175 · Cited by 903
Ratjen, F., & Döring, G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12567-6 · Cited by 885
Network-based prediction of drug combinations
Cheng, F., Kovács, I. A., & Barabási, A.-L. (2019) · Nature Communications · doi:10.1038/s41467-019-09186-x · Cited by 800
HER kinase inhibition in patients with HER2- and HER3-mutant cancers
Hyman, D. M., Piha-Paul, S. A., Won, H., Rodon, J., Saura, C., Shapiro, G. I., Juric, D., Quinn, D. I., Moreno, V., Doger, B., et al. (2018) · Nature · doi:10.1038/nature25475 · Cited by 780
The International IBD Genetics Consortium (IIBDGC), Ellinghaus, D., International Genetics of Ankylosing Spondylitis Consortium (IGAS), International PSC Study Group (IPSCSG), Genetic Analysis of Psoriasis Consortium (GAPC), Psoriasis Association Genetics Extension (PAGE), Jostins, L., Spain, S. L., Cortes, A., Bethune, J., et al. (2016) · Nature Genetics · doi:10.1038/ng.3528 · Cited by 751
Can you teach old drugs new tricks?
Nosengo, N. (2016) · Nature · doi:10.1038/534314a · Cited by 729
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
Sicklick, J. K., Kato, S., Okamura, R., Schwaederle, M., Hahn, M. E., Williams, C. B., De, P., Krie, A., Piccioni, D. E., Miller, V. A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0407-5 · Cited by 707
Are animal models predictive for humans?
Shanks, N., Greek, R., & Greek, J. (2009) · Philosophy, Ethics, and Humanities in Medicine · doi:10.1186/1747-5341-4-2 · Cited by 677
Animal models of ischemic stroke and their application in clinical research
Kleinschnitz, C., Fluri, F., & Schuhmann, M. (2015) · Drug Design, Development and Therapy · doi:10.2147/dddt.s56071 · Cited by 650
Buczkowicz, P., Hoeman, C., Rakopoulos, P., Pajovic, S., Letourneau, L., Dzamba, M., Morrison, A., Lewis, P., Bouffet, E., Bartels, U., et al. (2014) · Nature Genetics · doi:10.1038/ng.2936 · Cited by 647
Palmer, A. C., & Sorger, P. K. (2017) · Cell · doi:10.1016/j.cell.2017.11.009 · Cited by 642
Maeda, H., & Khatami, M. (2018) · Clinical and Translational Medicine · doi:10.1186/s40169-018-0185-6 · Cited by 491
Kleinschnitz, C., Grund, H., Wingler, K., Armitage, M. E., Jones, E., Mittal, M., Barit, D., Schwarz, T., Geis, C., Kraft, P., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000479 · Cited by 447
Self-citationNADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus–Accelerated Atherosclerosis
Gray, S. P., Di Marco, E., Okabe, J., Szyndralewiez, C., Heitz, F., Montezano, A. C., de Haan, J. B., Koulis, C., El-Osta, A., Andrews, K. L., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.132159 · Cited by 386
Self-citationVoigt, A. P., Mulfaul, K., Mullin, N. K., Flamme-Wiese, M. J., Giacalone, J. C., Stone, E. M., Tucker, B. A., Scheetz, T. E., & Mullins, R. F. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1914143116 · Cited by 374
Jha, J. C., Gray, S. P., Barit, D., Okabe, J., El-Osta, A., Namikoshi, T., Thallas-Bonke, V., Wingler, K., Szyndralewiez, C., Heitz, F., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013070810 · Cited by 352
Self-citationPrognostic versus predictive value of biomarkers in oncology
Oldenhuis, C. N. A. M., Oosting, S. F., Gietema, J. A., & de Vries, E. G. E. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.03.006 · Cited by 349
Liu, R., Wang, X., Aihara, K., & Chen, L. (2014) · Medicinal Research Reviews · doi:10.1002/med.21293 · Cited by 333
Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis
Cholon, D. M., Quinney, N. L., Fulcher, M. L., Esther, C. R., Das, J., Dokholyan, N. V., Randell, S. H., Boucher, R. C., & Gentzsch, M. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008680 · Cited by 320
Ogden, L. G., He, J., Lydick, E., & Whelton, P. K. (2000) · Hypertension · doi:10.1161/01.hyp.35.2.539 · Cited by 302
Assessment of network module identification across complex diseases
The DREAM Module Identification Challenge Consortium, Choobdar, S., Ahsen, M. E., Crawford, J., Tomasoni, M., Fang, T., Lamparter, D., Lin, J., Hescott, B., Hu, X., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0509-5 · Cited by 294
Dysfunctional nitric oxide signalling increases risk of myocardial infarction
CARDIoGRAM, Erdmann, J., Stark, K., Esslinger, U. B., Rumpf, P. M., Koesling, D., de Wit, C., Kaiser, F. J., Braunholz, D., Medack, A., et al. (2013) · Nature · doi:10.1038/nature12722 · Cited by 284
Cho, J. H., & Feldman, M. (2015) · Nature Medicine · doi:10.1038/nm.3897 · Cited by 260
Vinayagam, A., Gibson, T. E., Lee, H.-J., Yilmazel, B., Roesel, C., Hu, Y., Kwon, Y., Sharma, A., Liu, Y.-Y., Perrimon, N., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603992113 · Cited by 257
Poornima, P., Kumar, J. D., Zhao, Q., Blunder, M., & Efferth, T. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.06.018 · Cited by 248
From single drug targets to synergistic network pharmacology in ischemic stroke
Casas, A. I., Hassan, A. A., Larsen, S. J., Gomez-Rangel, V., Elbatreek, M., Kleikers, P. W. M., Guney, E., Egea, J., López, M. G., Baumbach, J., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820799116 · Cited by 239
Self-citationLarotrectinib: First Global Approval
Scott, L. J. (2019) · Drugs · doi:10.1007/s40265-018-1044-x · Cited by 237
Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer
Winter, J. M., Yeo, C. J., & Brody, J. R. (2013) · Journal of Surgical Oncology · doi:10.1002/jso.23192 · Cited by 234
Rationalizing the chemical space of protein–protein interaction inhibitors
Sperandio, O., Reynès, C. H., Camproux, A.-C., & Villoutreix, B. O. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2009.11.007 · Cited by 202
sc-PDB: an Annotated Database of Druggable Binding Sites from the Protein Data Bank
Kellenberger, E., Muller, P., Schalon, C., Bret, G., Foata, N., & Rognan, D. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci050372x · Cited by 201
Kotlyar, M., Pastrello, C., Malik, Z., & Jurisica, I. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1037 · Cited by 192
Gray, S. P., Di Marco, E., Kennedy, K., Chew, P., Okabe, J., El-Osta, A., Calkin, A. C., Biessen, E. A. L., Touyz, R. M., Cooper, M. E., et al. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.307012 · Cited by 189
Self-citationOptical Mapping of cAMP Signaling at the Nanometer Scale
Bock, A., Annibale, P., Konrad, C., Hannawacker, A., Anton, S. E., Maiellaro, I., Zabel, U., Sivaramakrishnan, S., Falcke, M., & Lohse, M. J. (2020) · Cell · doi:10.1016/j.cell.2020.07.035 · Cited by 181
Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing
Sadegh, S., Matschinske, J., Blumenthal, D. B., Galindez, G., Kacprowski, T., List, M., Nasirigerdeh, R., Oubounyt, M., Pichlmair, A., Rose, T. D., et al. (2020) · RePEc: Research Papers in Economics · Cited by 176
Self-citationNADPH oxidases as a source of oxidative stress and molecular target in ischemia/reperfusion injury
Kleikers, P. W. M., Wingler, K., Hermans, J. J. R., Diebold, I., Altenhöfer, S., Radermacher, K. A., Janssen, B., Görlach, A., & Schmidt, H. H. H. W. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0963-3 · Cited by 172
Self-citationExploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing
Sadegh, S., Matschinske, J., Blumenthal, D. B., Galindez, G., Kacprowski, T., List, M., Nasirigerdeh, R., Oubounyt, M., Pichlmair, A., Rose, T. D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17189-2 · Cited by 167
Self-citationJaniaud, P., Serghiou, S., & Ioannidis, J. P. A. (2019) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.12.003 · Cited by 165
Animal models for the study of arterial hypertension
Dornas, W., & Silva, M. E. (2011) · Journal of Biosciences · doi:10.1007/s12038-011-9097-y · Cited by 155
Casas, A. I., Geuss, E., Kleikers, P. W. M., Mencl, S., Herrmann, A. M., Buendia, I., Egea, J., Meuth, S. G., Lopez, M. G., Kleinschnitz, C., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705034114 · Cited by 152
Self-citationExploring the human diseasome: the human disease network
Goh, K.-I., & Choi, I. (2012) · Briefings in Functional Genomics · doi:10.1093/bfgp/els032 · Cited by 146
New drugs: where did we go wrong and what can we do better?
Wieseler, B., McGauran, N., & Kaiser, T. (2019) · BMJ · doi:10.1136/bmj.l4340 · Cited by 141
Identification of Druggable Cancer Driver Genes Amplified across TCGA Datasets
Chen, Y., McGee, J., Chen, X., Doman, T. N., Gong, X., Zhang, Y., Hamm, N., Ma, X., Higgs, R. E., Bhagwat, S. V., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098293 · Cited by 139
On the Clinical Pharmacology of Reactive Oxygen Species
Casas, A. I., Nogales, C., Mucke, H. A., Petraina, A., Cuadrado, A., Rojo, A. I., Ghezzi, P., Jaquet, V., Augsburger, F., Dufrasne, F., et al. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019422 · Cited by 134
Self-citationAdvances in gene therapy for cystic fibrosis lung disease
Yan, Z., McCray, P. B., & Engelhardt, J. F. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz139 · Cited by 132
Ridley, K., & Condren, M. E. (2020) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-25.3.192 · Cited by 131
Schmidt, K. T., Chau, C. H., Price, D. K., & Figg, W. D. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.765 · Cited by 130
Bashraheel, S. S., Dömling, A. S. S., & Goda, S. K. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110009 · Cited by 130
NADPH Oxidase, NOX1, Mediates Vascular Injury in Ischemic Retinopathy
Wilkinson‐Berka, J. L., Deliyanti, D., Rana, I., Miller, A. G., Agrotis, A., Armani, R., Szyndralewiez, C., Wingler, K., Touyz, R. M., Cooper, M. E., et al. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5357 · Cited by 123
Self-citationAKAP Signaling Islands: Venues for Precision Pharmacology
Omar, M. H., & Scott, J. D. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.09.007 · Cited by 123
Kast, R. E., Karpel‐Massler, G., & Halatsch, M. (2014) · Oncotarget · doi:10.18632/oncotarget.2408 · Cited by 121
Single-nuclei RNA-seq on human retinal tissue provides improved transcriptome profiling
Liang, Q., Dharmat, R., Owen, L. A., Shakoor, A., Li, Y., Kim, S., Vitale, A. T., Kim, I. K., Morgan, D. J., Liang, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12917-9 · Cited by 121
Smyth, L. M., Tamura, K., Oliveira, M., Ciruelos, E., Mayer, I. A., Sablin, M., Biganzoli, L., Ambrose, H. J., Ashton, J., Barnicle, A., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3953 · Cited by 118
Gray, S. P., Jha, J. C., Kennedy, K., van Bommel, E. J. M., Chew, P., Szyndralewiez, C., Touyz, R. M., Schmidt, H. H. H. W., Cooper, M. E., & Jandeleit-Dahm, K. A. M. (2017) · Diabetologia · doi:10.1007/s00125-017-4215-5 · Cited by 111
Self-citationCritical Review of Umbrella, Basket, and Platform Designs for Oncology Clinical Trials
Simon, R. M. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.814 · Cited by 107
Elexacaftor/Ivacaftor/Tezacaftor: First Approval
Hoy, S. M. (2019) · Drugs · doi:10.1007/s40265-019-01233-7 · Cited by 96
Calcium-dependent blood-brain barrier breakdown by NOX5 limits postreperfusion benefit in stroke
Casas, A. I., Kleikers, P. W. M., Geuß, E., Langhauser, F., Adler, T., Busch, D. H., Gailus‐Durner, V., de Angelis, M. H., Egea, J., López, M. G., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124283 · Cited by 94
Self-citationDavis, P. B., Yasothan, U., & Kirkpatrick, P. N. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3723 · Cited by 93
Pharmacology and Clinical Drug Candidates in Redox Medicine
Dao, V. T.-V., Casas, A. I., Maghzal, G. J., Seredenina, T., Kaludercic, N., Robledinos-Anton, N., Di Lisa, F., Stocker, R., Ghezzi, P., Jaquet, V., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6430 · Cited by 88
Self-citationMochida, K., Koda, S., Inoue, K., & Nishii, R. (2018) · Frontiers in Plant Science · doi:10.3389/fpls.2018.01770 · Cited by 83
L-Citrulline increases nitric oxide and improves control in obese asthmatics
Holguín, F., Grasemann, H., Sharma, S., Winnica, D., Wasil, K., Smith, V. L., Cruse, M. H., Perez, N., Coleman, E., Scialla, T. J., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.131733 · Cited by 77
A Therapy for Most with Cystic Fibrosis
Bear, C. E. (2020) · Cell · doi:10.1016/j.cell.2019.12.032 · Cited by 76
Halatsch, M.-E., Kast, R. E., Karpel-Massler, G., Mayer, B., Zolk, O., Schmitz, B., Scheuerle, A., Maier, L., Bullinger, L., Mayer-Steinacker, R., et al. (2021) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdab075 · Cited by 74
Improving Clinical Trial Efficiency: Thinking outside the Box
Mandrekar, S. J., Dahlberg, S. E., & Simon, R. M. (2015) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2015.35.e141 · Cited by 71
Erratum: Universal resilience patterns in complex networks
Gao, J., Barzel, B., & Barabási, A.-Ĺ. (2016) · Nature · doi:10.1038/nature18019 · Cited by 70
Langhauser, F., Casas, A. I., Dao, V.-T.-V., Güney, E., Menche, J., Geuß, E., Kleikers, P. W. M., López, M. G., Barabási, A.-Ĺ., Kleinschnitz, C., et al. (2018) · npj Systems Biology and Applications · doi:10.1038/s41540-017-0039-7 · Cited by 70
Self-citationChartier, M., Morency, L.-P., Zylber, M. I., & Najmanovich, R. (2017) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-017-0128-7 · Cited by 68
On the performance of de novo pathway enrichment
Batra, R., Alcaraz, N., Gitzhofer, K., Pauling, J. K., Ditzel, H. J., Hellmuth, M., Baumbach, J., & List, M. (2017) · npj Systems Biology and Applications · doi:10.1038/s41540-017-0007-2 · Cited by 58
Self-citationElbatreek, M. H., Sadegh, S., Anastasi, E., Güney, E., Nogales, C., Kacprowski, T., Hassan, A., Teubner, A., Huang, P., Hsu, C., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000885 · Cited by 56
Self-citationOn the limits of active module identification
Lazareva, O., Baumbach, J., List, M., & Blumenthal, D. B. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab066 · Cited by 52
Self-citationPersonalized Cardiovascular Medicine and Drug Development
Loscalzo, J. (2012) · Circulation · doi:10.1161/circulationaha.111.089243 · Cited by 49
Toward a More Precise Future for Oncology
Murciano-Goroff, Y. R., Taylor, B. S., Hyman, D. M., & Schram, A. M. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.014 · Cited by 48
Proximal Pathway Enrichment Analysis for Targeting Comorbid Diseases via Network Endopharmacology
Aguirre‐Plans, J., Piñero, J., Menche, J., Sanz, F., Furlong, L. I., Schmidt, H. H. H. W., Oliva, B., & Güney, E. (2018) · Pharmaceuticals · doi:10.3390/ph11030061 · Cited by 46
Self-citationAguirre‐Plans, J., Piñero, J., Sanz, F., Furlong, L. I., Fernández‐Fuentes, N., Oliva, B., & Güney, E. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.02.027 · Cited by 45
Nosalski, R., Mikolajczyk, T. P., Siedliński, M., Saju, B., Kozioł, J., Maffia, P., & Guzik, T. J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105235 · Cited by 42
Zimmer, D. P., Shea, C. M., Tobin, J. V., Tchernychev, B., Germano, P., Sykes, K., Banijamali, A. R., Jacobson, S., Bernier, S. G., Sarno, R., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00419 · Cited by 35
Pool, F. M., Kiel, C., Serrano, L. G., & Luthert, P. J. (2020) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-019-0039-5 · Cited by 32
Self-citationGarmaroudi, F. S., Handy, D. E., Liu, Y., & Loscalzo, J. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004822 · Cited by 31
Kleikers, P. W. M., Hooijmans, C. R., Göb, E., Langhauser, F., Rewell, S. S. J., Radermacher, K. A., Ritskes-Hoitinga, M. J., Howells, D. W., Kleinschnitz, C., & Schmidt, H. H. H. W. (2015) · Scientific Reports · doi:10.1038/srep13428 · Cited by 29
Self-citationSoluble Guanylate Cyclase Agonists Induce Bronchodilation in Human Small Airways
Koziol‐White, C. J., Ghosh, A., Sandner, P., Erzurum, S., Stuehr, D. J., & Panettieri, R. A. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0001oc · Cited by 25
Early Patient Stratification and Predictive Biomarkers in Drug Discovery and Development
Laifenfeld, D., Drubin, D. A., Catlett, N. L., et al. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7210-1_38 · Cited by 24
Impact of Biomarkers on Personalized Medicine
Carrigan, P. E., & Krahn, T. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_24 · Cited by 23
Kleinschnitz, C., Mencl, S., Kleikers, P. W. M., Schuhmann, M. K., López, M. G., Casas, A. I., Sürün, B., Reif, A., & Schmidt, H. H. H. W. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16657094 · Cited by 22
Self-citationSimple and complex retinal dystrophies are associated with profoundly different disease networks
Kiel, C., Lastrucci, C., Luthert, P. J., & Serrano, L. G. (2017) · Scientific Reports · doi:10.1038/srep41835 · Cited by 19
Self-citationAnimal Models in Obesity and Hypertension
Segal‐Lieberman, G., & Rosenthal, T. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0338-3 · Cited by 17
Luthert, P. J., & Kiel, C. (2020) · Network and Systems Medicine · doi:10.1089/nsm.2020.0005 · Cited by 13
Self-citationNogales, C., Grønning, A. G. B., Sadegh, S., Baumbach, J., & Schmidt, H. H. H. W. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_386 · Cited by 11
Self-citationThe holy grail of cystic fibrosis research: pharmacological repair of the F508del-CFTR mutation.
Maiuri, L., Stefano, D. D., Raia, V., & Kroemer, G. (2015) · PubMed · doi:10.3978/j.issn.2305-5839.2015.02.32 · Cited by 7
Luthert, P. J., Serrano, L. G., & Kiel, C. (2018) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-080917-013356 · Cited by 5
Self-citation
Cited by
Zhang, P., Zhang, D., Zhou, W., Wang, L., Wang, B., Zhang, T., & Li, S. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad518 · Cited by 675
AI-powered therapeutic target discovery
Pun, F. W., Ozerov, I. V., & Zhavoronkov, A. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.06.010 · Cited by 341
Network pharmacology approaches for research of Traditional Chinese Medicines
LI, X., LIU, Z., LIAO, J., CHEN, Q., LU, X., & FAN, X. (2023) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(23)60429-7 · Cited by 308
Metadata
- Authors
- Nogales, C., Mamdouh, Z. M., List, M., Kiel, C., Casas, A. I., & Schmidt, H. H. H. W.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2022-02
- Volume
- 43
- Issue
- 2
- Pages
- 136-150
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W4200045218
- Cited by
- 1,201
- References
- 110
- FWCI
- 13.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.